There's no good answer. If his cancer is possibly fatal or requiring extensive treatment, I would cut him loose with a small amount of equity - in the order of 10 to 20% for his contribution. Doing otherwise will likely tank the company. If it can't survive without him, maybe it's time to call it quits.